Psycho-Education Physical Exercise Effects: does treating subsyndromal depression improve depression- and diabetes-related outcomes?

Conditions

Type 2 diabetes/subsyndromal depression Nutritional, Metabolic, Endocrine Type 2 diabetes

Mirjana Pibernik-Okanović, Norbert Hermanns, Dea Ajduković, Jadranka Kos, Manja Prašek et al. (7 authors)

Trials2015-07-1433 citations

Improvement in Depressive Symptoms Is Associated with Reduced Oxidative Damage and Inflammatory Response in Type 2 Diabetic Patients with Subsyndromal Depression: The Results of a Randomized Controlled Trial Comparing Psychoeducation, Physical Exercise, and Enhanced Treatment as Usual

Marijana Vučić Lovrenčić, Mirjana Pibernik-Okanović, Mario Šekerija, Manja Prašek, Dea Ajduković et al. (7 authors)

International Journal of Endocrinology2015-01-0117 citations

10.1155/2015/210406

Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual.

Pibernik-Okanović M, Ajduković D, Lovrenčić MV, Hermanns N.

2011-01-2111 citations

10.1186/1745-6215-12-17

Interventions

1. Psycho-educational intervention: The intervention will comprise 6 interactive small-group meetings (4 - 6 members), each lasting for 60 - 90 minutes. The topics will include: 1.1. Symptoms of depr

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Type 2 diabetes 2. Aged 18 - 60 years, either sex 3. Subsyndromal depression as determined by the screenings instruments (Patient Health Questionnaire-2 [PHQ-2], Center for Epidemiologic Studies Depression Scale [CES-D]) and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) 4. Willing to participate (signing a written informed consent)

Exclusion criteria

Exclusion criteria: 1. Poor literacy 2. Mobility difficulties 3. Visual impairment 4. Drinking problems 5. Psychosis in personal medical history 6. Medical contraindications for physical exercise (heart attack or stroke in the past six months, chest pain, dizziness, fainting attacks, shortness of breath)

Design outcomes

Primary

Measure	Time frame
Depressive symptoms, measured after the treatment (i.e. after six weeks for the "diabetes treatment as usual" group), and after six- and twelve-month follow-up periods.	—

Secondary

Measure	Time frame
1. Self-management of diabetes, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 2. Metabolic control, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 3. Diabetes-related distress, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 4. Health-related quality of life, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 5. Treatment satisfaction, measured after the treatment	—

Measure

Time frame

1. Self-management of diabetes, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 2. Metabolic control, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 3. Diabetes-related distress, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 4. Health-related quality of life, measured at six weeks for the "diabetes treatment as usual" group, and after six- and twelve-month follow-up periods 5. Treatment satisfaction, measured after the treatment

—

Countries

Croatia

Outcome results

None listed